Poor Response to Initial Therapy for Migraine

Slides:



Advertisements
Similar presentations
Visit:
Advertisements

The opioid registry is here!
The Patient Experience With Systemic Lupus Erythematosus
Godrej Prakriti Sodepur | Godrej Prakriti Kolkata
Moderate-to-Severe Asthma Management
Talking to Patients About HCV Treatment
Giftalove Best Cake Offers
Primary Care Challenges in Depression - To Treat or Refer?
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons From Clinical Trials.
Program Themes. Consulting on Common Concerns in PAH: How Would You Manage These Patients?
RESISTANT HYPERTENSION OR POOR PATIENT ADHERENCE? TIPS TO GAIN CONTROL
Management of Mild to Moderate Asthma
Post-autologous Transplant Therapy for Hodgkin Lymphoma
Improving the Diagnosis and Treatment of Seizures in Long-term Care
Glaucoma Progression.
The Nurse View.
Current Controversies in Multiple Sclerosis Management
Migraine Prevention Therapy: Avoiding Overuse of Medications
Disclaimer. LEGAL AND POLICY CONSIDERATIONS OF NALOXONE FOR OPIOID TOXICITY REVERSAL.
Program Goals. Implementing the Updated American Thyroid Association Guidelines and Recommendations for RAI-R DTC.
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.
Patient-Centered Care in Cystic Fibrosis
Case Challenges in Chronic Migraine
Resistant Hypertension
Successful Obesity Management and Counseling:
nAMD: Switching Therapies - what you need to know
Goals. Achieving HbA1c Goals: Applying Guidelines to Intensify Therapy in Patients With Diabetes.
Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.
The Vicious Cycle of Chronic Migraine How Can the Physician Help?
Engaging and Educating the Multidisciplinary Healthcare Team in HCV Care.
Talking to Patients About Diabetes Management
Treatment Options to Consider
Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.
From Symptom Management to Communication in Advanced GI Cancers
Management of Adolescents With Seizures
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Practical Guidance on Using New Therapies for Relapsed/ Refractory Follicular Lymphoma and Chronic Lymphocytic Leukemia.
Risk Assessment in PAH.
EHL Technologies in Hemophilia Care
2013 World Symposium on PH CTEPH Diagnosisa 2013 World Symposium on PH (cont) CTEPH Treatmenta.
Program Goals. Implementing the Updated American Thyroid Association Guidelines and Recommendations for RAI-R DTC.
Program Goals Disclaimer Overview Assessing Disease Activity.
Charting Progress in MS Treatment:
Current and Future Perspectives on Migraine Prevention Therapy
Case: A 28-Year-Old Man. When a 5-ASA Agent No Longer Maintains Remission in a Patient With Ulcerative Colitis.
An Interprofessional Perspective on the Safe and Appropriate Use of Opioid Analgesics.
Interprofessional Approaches: Managing AEs of Novel Therapies for NHL/CLL.
Introduction. Clinical Scenario: Encouraging Adherence in Patients with Schizophrenia.
Navigating Treatment Options in PAH
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.
When Is Intrathecal Drug Delivery Appropriate?
Program Goals Disclaimers Defining Refractory Seizures.
Managing Patients with Relapsed CLL who Discontinue BCR Signaling Inhibitors.
A Guideline-Based Approach to HCV Care
Insulin in Diabetes Management: Effective Patient Selection Is Key
Critical Decision Points in Insomnia
Controlling Elevated Blood Pressure
A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.
Improving Adherence to Antiplatelet Therapy After an ACS Event
Live on PAH: Breathing Life Into Patients With PAH
Clinical Challenges and Updates in Managing Seizure Clusters
Program Goal. Program Goal Disclaimer Overview.
When Is Intrathecal Drug Delivery Appropriate?
Strategies for Infection Control in Cystic Fibrosis
Issues in Patients With Severe Epilepsy
Diagnostic Criteria Migraine Without Aura
Mitigating Side Effects and Optimizing Compliance With Oral Therapies in CLL.
Visit us:
Monoclonal Antibodies in Migraine Prevention: What the Primary Care Physician Needs to Know.
Ask the Psoriasis Expert
Presentation transcript:

Poor Response to Initial Therapy for Migraine

Migraine Treatment

Case Study Jane

One-Month Follow-Up Visit

Headache Diary

Questions That Should Be Asked at a Follow-Up Visit

Questions at Follow-Up Visit (cont)

Reasons for Poor Response

Medication Stay the Course

Medication Switch Shared Decision Making

Medication Switch Options

Medication Switch Options (cont)

Medication Switch Options (cont)

Medication Switch Options (cont)

Medication Switch Options (cont)

Transforming to Chronic Migraine

Treatment Options for Jane

Treatment Toolbox

Adherence Issues

Key Messages

Abbreviations

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.